Pvg Asset Management Corp Bristol Myers Squibb CO Transaction History

Pvg Asset Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $23,636 - $26,244	-371 Reduced 9.88%	3,384 $216,000
Q1 2023 Jul 24, 2023	BUY	$65.71 - $74.53 $246,741 - $279,860	3,755 New	3,755 $260,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $1.44 Million - $1.62 Million	-24,340 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $15,172 - $22,049	327 Added 1.36%	24,340 $1.36 Million
Q4 2019 Feb 26, 2020	SELL	$49.21 - $64.19 $588,945 - $768,225	-11,968 Reduced 33.26%	24,013 $1.54 Million
Q3 2019 Nov 15, 2019	SELL	$42.77 - $50.71 $89,432 - $106,034	-2,091 Reduced 5.49%	35,981 $1.82 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $1.7 Million - $1.88 Million	38,072 New	38,072 $1.73 Million
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $466,584 - $605,047	-9,569 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $2.47 Million - $2.79 Million	-44,806 Reduced 82.4%	9,569 $594,000
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $2.75 Million - $3.42 Million	54,375 New	54,375 $3.01 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.